- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01496482
Comparison of Evaporimetry With the Established Methods of Tear Film Measurement
Purpose:
To establish whether there is a correlation between dry eye symptoms, age and gender, a difference in symptom intensity in different times of the day, which test (Schirmer or TBUT) better correlates with dry eye symptoms, whether it is possible to reliably use cheap, easy to use hygrometer in everyday clinical setting, and finally whether there is statistically significant correlation between applied tests (TBUT, Schirmer and evaporimetry).
Methods:
Subjects: 45 in group without dry eye related symptoms, and 45 in group with symptoms.
Examination included structured case history (questionnaire), slit lamp examination with fluorescein staining, periocular evaporimetry, TBUT test and Schirmer test.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Purpose:
The purpose of this study was to establish whether there is a correlation between dry eye symptoms, age and gender, any difference in symptom intensity in different times of the day, which test (Schirmer or TBUT) better correlates with dry eye symptoms, whether it is possible to reliably use cheap, easy to use hygrometer in everyday clinical setting, and, finally, whether there is statistically significant correlation between applied tests (TBUT, Schirmer and evaporimetry).
Methods:
Subjects were divided in two groups: 45 in group without dry eye related symptoms, and 45 in group with symptoms.
Examination was performed in the following sequence:
- structured case history (questionnaire),
- evaporimetry
- slit lamp examination with fluorescein staining,
- TBUT test and
- Schirmer test I (without anesthetic, closed eyes)
Case history consisted of the following questions:irritation more pronounced on wind? irritation during reading and/or watching TV or computer? irritation more pronounced during winter? gritty sensation in the eyes? irritation more pronounced in the morning or evening? All answers, except to the last question, were graded from 0 (no complaints) to 3 (severe).
Evaporimetry was performed using commercially available hygrometer from HYGROTEC (Titisee-Neustadt, Germany), installed in swimming goggles with its front part sawn off.
First measurement was performed by measuring for 5 minutes with eyes closed. Second measurement also lasted 5 minutes, with eyes kept open, normal blinking, and with subject fixating at one point in distance, with no eye movements.
Measured parameters included:
basal φ (%): relative environment humidity before measurement basal T: environment temperature before measurement closed eye φ (%): relative humidity in front of closed eye open eye φ (%): relative humidity in front of open eye C/O: ratio of φ (%) closed/open eye
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Zagreb, Croatia, HR-10000
- Zagreb University Hospital Eye Department
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients with or without dry eye symptoms
Exclusion Criteria:
- minors
- pregnant women
- patients with acute eye conditions (inflammation, allergy, trauma)
- patients with chronic eye diseases requiring continuous topical treatment (i.e.glaucoma)
- ocular surface scarring
- patients who did not sign informed consent.
Study Plan
How is the study designed?
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients without dry eye symptoms
Patients without dry eye symptoms as measured by standard questionnaire.
|
As study compared specific diagnostic procedures, no intervention was done or compared.
|
|
Patients with dry eye symptoms
Patients with dry eye symptoms as measured by standard questionnaire.
|
As study compared specific diagnostic procedures, no intervention was done or compared.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tear evaporation
Time Frame: 10 minutes
|
Five minutes of tear evaporation measurement with eyes closed and five with open, normal blinking.
|
10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of tear evaporation to symptoms score
Time Frame: 15 minutes (10 minutes tear evaporation, 5 minutes symptoms score recording)
|
Tear evaporation measurement compared to dry eye symptoms score (0-15 points).
|
15 minutes (10 minutes tear evaporation, 5 minutes symptoms score recording)
|
|
Comparison of tear evaporation to Tear Film Break-up Time (TBUT)
Time Frame: 15 minutes (10 minutes evaporation measurement, 5 minutes TBUT measurement)
|
Comparison of tear evaporation to Tear Film Break-up Time (seconds).
|
15 minutes (10 minutes evaporation measurement, 5 minutes TBUT measurement)
|
|
Comparison of tear evaporation to Schirmer test
Time Frame: 15 minutes (10 minutes tear evaporation measurement, 5 minutes Schirmer test)
|
Comparison of tear evaporation to Schirmer test (mm)
|
15 minutes (10 minutes tear evaporation measurement, 5 minutes Schirmer test)
|
|
Comparison of tear evaporation to corneal staining
Time Frame: 12 minutes (10 minutes tear evaporation measurements, 2 minutes corneal staining assessment)
|
Comparison of tear evaporation to corneal staining using fluorescein (score 1-3): 1:5-10 corneal stains at six o'clock; 2: 10-25 corneal stains; 3: more than 26 diffuse corneal stains |
12 minutes (10 minutes tear evaporation measurements, 2 minutes corneal staining assessment)
|
|
Comparison of tear evaporation to conjunctival hyperemia
Time Frame: 11 minutes (10 minutes evaporation measurement, 1 minute conjunctival hyperemia assessment)
|
Comparison of tear evaporation to conjunctival hyperemia (score 1-3): 1: minimal; 2: moderate; 3: severe |
11 minutes (10 minutes evaporation measurement, 1 minute conjunctival hyperemia assessment)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Igor Petricek, MD, PhD, Zagreb University Hospital Eye Department, Zagreb, Croatia
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UZagreb Eye 1
- Dry Eye 1 (Other Identifier: Zagreb University Hospital Eye Department, Zagreb, Croatia)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye Syndromes
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Chronic Dry Eye
-
Southern College of OptometryNot yet recruitingEye Diseases | Dry Eye | Dry Eye Syndromes | Dry Eyes Chronic
-
University of MiamiNot yet recruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
-
Singapore National Eye CentreThe Eye Hospital of Wenzhou Medical UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityRecruitingDry Eye | Dry Eye Disease (DED)Hong Kong
-
Neuro-Ophthalmology of TexasHarrow IncRecruiting
-
Vision Innovation Centers of Pennsylvania, LLC...Nordic Pharma, USARecruiting
-
Demaod LtdNot yet recruitingDry Eye | Dry Eye Syndromes
-
Eye & ENT Hospital of Fudan UniversityRecruiting
-
Southern College of OptometryRecruitingEye Diseases | Dry Eye | Eyes Dry ChronicUnited States
Clinical Trials on Only measurements done on subjects in both groups.
-
Memorial Sloan Kettering Cancer CenterCompleted
-
University of AlcalaCompletedMyofascial Trigger Point PainSpain
-
Assiut UniversitySouth Egypt Cancer InstituteActive, not recruitingAcute Lymphoblastic Leukemia ALLEgypt
-
Memorial Sloan Kettering Cancer CenterBoehringer Ingelheim; National Comprehensive Cancer NetworkCompletedHead and Neck Cancer | Squamous Cell CancerUnited States